Calcipotriol

Author:Prof. Dr. med. Peter Altmeyer

Co-Autor:Dr. med. Florian Weid

All authors of this article

Last updated on: 18.12.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Vitamin D3 analogue.

IndicationThis section has been translated automatically.

Mild to moderate psoriasis vulgaris of the plaque type with an extension of < 30% of the body surface.

Dosage and method of useThis section has been translated automatically.

Ointment/cream/compound: Apply 2 times/day to the affected areas of skin (max. 30% of the body surface, max. 15 g ointment/cream/day, max. for 6 weeks) The cream base or a solution can also be used in the area of the capillitium, as it can be washed out easily!

Standard concentrationThis section has been translated automatically.

0.005% in lotions, ointments, creams.

Undesirable effectsThis section has been translated automatically.

  • Cream/Ointment: Occasional temporary itching, burning and erythema, especially in intertriginous areas. Occurrence of facial and perioral dermatitis (see also eczema, contact eczema, allergic), which disappears after the end of treatment. Continuous use of high doses may result in hypercalcemia and/or increased urinary calcium excretion.
  • Solution: See above, in addition possibly worsening of psoriasis, sensitivity to light, rarely hypercalcemia, hypercalzuria.

InteractionsThis section has been translated automatically.

Calcium preparations, salicylic acid, cream bases without active ingredients.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, children and adolescents < 18 years, large-area application (> 30% KO), psoriasis punctata, pustular psoriasis, diseases of the calcium metabolism, severe liver and kidney diseases.

IncompatibilityThis section has been translated automatically.

Exteriors containing salicylic acid inactivate calcipotriol when used simultaneously and even after hours of use.

PreparationsThis section has been translated automatically.

Daivonex® - cream, ointment, solution

Daivobet® - gel, ointment (combination with betamethasone dipropionate)

Xamiol® - gel (combination with betamethasone dipropionate)

Enstilar® - foam (spray foam galenic, also combination with betamethasone diproprionate)

Dovobet® - gel (combination with betamethasone diproprionate)

Calcipotriol - Solution

Calcipotriol Comp - Ointment

PatientinformationThis section has been translated automatically.

Wash your hands after use to avoid transfer to the facial skin and other non-diseased skin areas!

Authors

Last updated on: 18.12.2020